The 11 most innovative medical devices of 2017

Share

9. Johnson & Johnson – Ethicon: Evarrest fibrin sealant patch

evarrest_cardthree

[Image from Ethicon]

The Evarrest fibrin sealant patch from Ethicon is a flexible sealant patch designed for general hemostasis. It has a durable mechanical structure for integrated clot formation and has hemostatic efficacy upon first-use attempt, according to the company. It doesn’t require preparation, mixing or moistening – and is ready right out of the box. It has a shelf life of 30 months as well. Thousands of woven fibers and active human biologics work together to stop bleeding in tumor bed, liver resection and aortic reconstruction in 3 minutes. When applied, blood passes through the patch and clot formation begins at the bleeding surface and within the patch. The adhesives on the patch form a tight physical seal with tissue and the patch keeps its flexible barrier to bleeding. The patch is fully absorbed in eight weeks.

Next >>

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.


Register now with the code "TAVR" and save 15% today.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12

Speak Your Mind

*